Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
1 Despite these constraints, the commercial consequence has been significant: Medicare logged $27.5 billion in gross GLP-1 spending across 21.8 million claims in 2024, entirely under FDA-approved indications other than obesity
The data supported reduced-frequency dosing as a viable maintenance strategy patients maintained most of their weight loss at lower dosing frequency
While the lower dose may not achieve the desired weight loss, it cant be considered harmful in any way. Even the innovator brands Ozempic for diabetes and Wegovy for obesity both carry the same active ingredient, semaglutide
Mounjaro side effects Common side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain Less common but more serious side effects include an allergic reaction, pancreatitis, gallbladder problems, vision changes, and kidney damage
